A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases
Authors:
- William R. JarnaginWJWilliam R. Jarnagin
- Kevin ConlonKCKevin Conlon
- Jessica BodniewiczJBJessica Bodniewicz
- Ellen DoughertyEDEllen Dougherty
Open Access
Abstract
BACKGROUND Laparoscopy may identify occult metastatic disease and prevent unnecessary laparotomy in some patients with potentially resectable colorectal liver metastases but is unnecessary in the majority of individuals who undergo resection. The objectives of the current study were to assess the impact of laparoscopy after extensive preoperative imaging and to determine whether a preoperative clinical risk score can identify those patients most likely to benefit from the procedure. METHODS Between December 1997 and July 1999, 103 consecutive patients with potentially resectable colorectal liver metastases underwent laparoscopy prior to planned laparotomy and partial hepatectomy. Surgical findings, length of hospital stay, and hospital charges were analyzed. Patients were assigned a clinical risk score (CRS) based on five factors related to the primary tumor and the hepatic disease. The likelihood of finding occult unresectable disease and the yield of laparoscopy were analyzed with respect to the CRS. RESULTS Seventy‐seven patients (75%) underwent resection. Laparoscopy identified 14 of 26 patients with unresectable disease, 10 of whom were spared an unnecessary laparotomy. In patients who underwent biopsy only, the laparoscopic identification of unresectable disease shortened the hospital stay (1.2 ± 0.6 days vs. 5.8 ± 2.3 days; p = 0.0001) and reduced the total hospital charges by 55% (P = 0.0001). The CRS predicted the likelihood of occult unresectable disease, which was 12% in those with a score ≤ 2 but increased to 42% in those with a score > 2 (P = 0.001). If laparoscopy were used only in high risk patients (CRS > 2), 57 laparoscopies would have been avoided and the net savings doubled. CONCLUSIONS With extensive preoperative imaging, the vast majority of patients with potentially resectable hepatic colorectal metastases do not benefit from laparoscopy. However, in the minority of patients with occult unresectable disease, laparoscopy prevents unnecessary laparotomy and reduces hospital stay and the total hospital charges. The CRS, previously shown to predict survival after hepatic resection, identifies those high risk patients most likely to benefit from laparoscopy and may improve resource utilization. Cancer 2001;91:1121–8. © 2001 American Cancer Society.Keywords
This publication has 14 references indexed in Scilit:
- A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignanciesJournal of Gastrointestinal Surgery, 2000
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999
- Liver Resection for Metastatic Colorectal Cancer: Assessing the Risk of Occult Irresectable DiseaseJournal of the American College of Surgeons, 1999
- Intraoperative determinants of unresectability for patients with colorectal hepatic metastasesCancer, 1998
- Ninety-Six Five-Year Survivors After Liver Resection for Metastatic Colorectal CancerJournal of the American College of Surgeons, 1997
- Staging Laparoscopy with Laparoscopic Ultrasonography: Optimizing Resectability in Hepatobiliary and Pancreatic MalignancyJournal of the American College of Surgeons, 1997
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Role of staging laparoscopy in the treatment of hepatic malignancyThe American Journal of Surgery, 1994
- Resection of Hepatic Metastases from Colorectal Cancer Biologic PerspectivesAnnals of Surgery, 1989
- Multivariate Analysis of a Personal Series of 247 Consecutive Patients with Liver Metastases from Colorectal CancerAnnals of Surgery, 1984